This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Westra TA, Rogoza R, Ferko N, Tamminga JJ, Drummond MF, Wilschut JC, Postma MJ.Cost-effectiveness of a prophylactic human papilloma virus 16/18 vaccine for 12-year-old Dutch girls. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: 433 abstr. PIN16, 8 Nov 2008
Gauthier A, Moore L, Martín-Escudero V, Peterson C, Pérez I, de Sanjosé S.Cost-effectiveness of Cervarix TM, a prophylactic cervical cancer vaccine, in Spain. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: 431-432 abstr. PIN12, 8 Nov 2008
Väänänen JJP, Herse F, Korkeamäki J, Parvinen PMT, Remy O.Cost-effectiveness of quadrivalent HPV vaccination in Finland. 11th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research: 431 abstr. PIN11, 8 Nov 2008
Rights and permissions
About this article
Cite this article
Value of HPV vax confirmed in European countries. Pharmacoecon. Outcomes News 567, 5 (2008). https://doi.org/10.2165/00151234-200805670-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805670-00005